{"id":3500,"date":"2013-09-06T13:21:00","date_gmt":"2013-09-06T13:21:00","guid":{"rendered":"http:\/\/test-medrazgl.aed-baza.si\/?p=3500"},"modified":"2013-09-10T06:49:35","modified_gmt":"2013-09-10T06:49:35","slug":"survival-of-patients-with-ovarian-cancer","status":"publish","type":"post","link":"https:\/\/medrazgl.si\/en\/survival-of-patients-with-ovarian-cancer\/","title":{"rendered":"Survival of Patients with Ovarian Cancer"},"content":{"rendered":"<p align=\"left\">Data from 282 patients who were first treated for epithelial ovarian malignoma at the Institute of Oncology and Gynecological clinic in Ljubljana between 1990 and 1992 were analysed retrospectively. The patients were followed through 1997.\u00a0The survival rates were determinated by Kaplan\u00adMeier method. For establishment of hazard ratios Cox analysis was used.\u00a0The five-year survival rates for different prognostic factors are as follows: 74 % for borderline patients and 38 for patients with carcinomas; by stage (I-IV) 88, 48, 26 and 12 %; by cancer grades (1-3) 69, 49, 26 %, respectively. Concerning age 50 older patients survive five years in 31 %, but younger in 61 %. The group with the diameter of residual implants after surgery smaller then 1 cm has 73 % five-year survival, but the other group 18 %.\u00a0After multivariate analysis the prognostic factors which were still significant are: stage, age high\u00ader then 50, the diameter of residual implants after first surgery greater than 1 cm, and type of pri\u00admary treatment for the whole cohort and the one of higher stages (III and IV) The type of prima\u00adry treatment was not significant for the group with the lower stages (I and II) of cancer.\u00a0An understanding of the influence of these prog\u00adnostic factors on the survival rate in epithelial ovarian malignoma offers the opportunity to sur\u00advey the situation in Slovenia and to compare our cohort with those in cancer centres throughout the world.<\/p>\n","protected":false},"excerpt":{"rendered":"<p>Data from 282 patients who were first treated for epithelial ovarian malignoma at the Institute of Oncology and Gynecological clinic in Ljubljana between 1990 and 1992 were analysed retrospectively. The patients were followed through 1997.\u00a0The survival rates were determinated by Kaplan\u00adMeier method. For establishment of hazard ratios Cox analysis was used.\u00a0The five-year survival rates for [&hellip;]<\/p>\n","protected":false},"author":17,"featured_media":0,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"_acf_changed":false,"footnotes":"","_links_to":"","_links_to_target":""},"categories":[338,407,421,436],"tags":[],"class_list":["post-3500","post","type-post","status-publish","format-standard","hentry","category-4-1999-archive","category-clinical-research-paper","category-gynecology-and-obstetrics","category-oncology"],"acf":[],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v27.5 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>Survival of Patients with Ovarian Cancer - Dru\u0161tvo Medicinski razgledi<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/medrazgl.si\/prezivetje-bolnic-z-rakom-jajcnikov\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Survival of Patients with Ovarian Cancer - Dru\u0161tvo Medicinski razgledi\" \/>\n<meta property=\"og:description\" content=\"Data from 282 patients who were first treated for epithelial ovarian malignoma at the Institute of Oncology and Gynecological clinic in Ljubljana between 1990 and 1992 were analysed retrospectively. The patients were followed through 1997.\u00a0The survival rates were determinated by Kaplan\u00adMeier method. For establishment of hazard ratios Cox analysis was used.\u00a0The five-year survival rates for [&hellip;]\" \/>\n<meta property=\"og:url\" content=\"https:\/\/medrazgl.si\/prezivetje-bolnic-z-rakom-jajcnikov\/\" \/>\n<meta property=\"og:site_name\" content=\"Dru\u0161tvo Medicinski razgledi\" \/>\n<meta property=\"article:published_time\" content=\"2013-09-06T13:21:00+00:00\" \/>\n<meta property=\"article:modified_time\" content=\"2013-09-10T06:49:35+00:00\" \/>\n<meta name=\"author\" content=\"Urban Neudauer\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Urban Neudauer\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"1 minute\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/medrazgl.si\\\/prezivetje-bolnic-z-rakom-jajcnikov\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/medrazgl.si\\\/prezivetje-bolnic-z-rakom-jajcnikov\\\/\"},\"author\":{\"name\":\"Urban Neudauer\",\"@id\":\"https:\\\/\\\/medrazgl.si\\\/#\\\/schema\\\/person\\\/39b1336c1302c42805280dd6a1e7069c\"},\"headline\":\"Survival of Patients with Ovarian Cancer\",\"datePublished\":\"2013-09-06T13:21:00+00:00\",\"dateModified\":\"2013-09-10T06:49:35+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/medrazgl.si\\\/prezivetje-bolnic-z-rakom-jajcnikov\\\/\"},\"wordCount\":222,\"commentCount\":0,\"articleSection\":[\"4\",\"Clinical research paper\",\"Gynecology and Obstetrics\",\"Oncology\"],\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"CommentAction\",\"name\":\"Comment\",\"target\":[\"https:\\\/\\\/medrazgl.si\\\/prezivetje-bolnic-z-rakom-jajcnikov\\\/#respond\"]}]},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/medrazgl.si\\\/prezivetje-bolnic-z-rakom-jajcnikov\\\/\",\"url\":\"https:\\\/\\\/medrazgl.si\\\/prezivetje-bolnic-z-rakom-jajcnikov\\\/\",\"name\":\"Survival of Patients with Ovarian Cancer - Dru\u0161tvo Medicinski razgledi\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/medrazgl.si\\\/#website\"},\"datePublished\":\"2013-09-06T13:21:00+00:00\",\"dateModified\":\"2013-09-10T06:49:35+00:00\",\"author\":{\"@id\":\"https:\\\/\\\/medrazgl.si\\\/#\\\/schema\\\/person\\\/39b1336c1302c42805280dd6a1e7069c\"},\"breadcrumb\":{\"@id\":\"https:\\\/\\\/medrazgl.si\\\/prezivetje-bolnic-z-rakom-jajcnikov\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/medrazgl.si\\\/prezivetje-bolnic-z-rakom-jajcnikov\\\/\"]}]},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/medrazgl.si\\\/prezivetje-bolnic-z-rakom-jajcnikov\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/medrazgl.si\\\/en\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Survival of Patients with Ovarian Cancer\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/medrazgl.si\\\/#website\",\"url\":\"https:\\\/\\\/medrazgl.si\\\/\",\"name\":\"Dru\u0161tvo Medicinski razgledi\",\"description\":\"Dru\u0161tvo Medicinski razgledi\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/medrazgl.si\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/medrazgl.si\\\/#\\\/schema\\\/person\\\/39b1336c1302c42805280dd6a1e7069c\",\"name\":\"Urban Neudauer\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/9dcee367d5b99deae63e16a3c461f1a7dae2d29d171f2dbc5f3de73145bb4f36?s=96&d=mm&r=g\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/9dcee367d5b99deae63e16a3c461f1a7dae2d29d171f2dbc5f3de73145bb4f36?s=96&d=mm&r=g\",\"contentUrl\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/9dcee367d5b99deae63e16a3c461f1a7dae2d29d171f2dbc5f3de73145bb4f36?s=96&d=mm&r=g\",\"caption\":\"Urban Neudauer\"},\"url\":\"https:\\\/\\\/medrazgl.si\\\/en\\\/author\\\/urban-neudauer\\\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Survival of Patients with Ovarian Cancer - Dru\u0161tvo Medicinski razgledi","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/medrazgl.si\/prezivetje-bolnic-z-rakom-jajcnikov\/","og_locale":"en_US","og_type":"article","og_title":"Survival of Patients with Ovarian Cancer - Dru\u0161tvo Medicinski razgledi","og_description":"Data from 282 patients who were first treated for epithelial ovarian malignoma at the Institute of Oncology and Gynecological clinic in Ljubljana between 1990 and 1992 were analysed retrospectively. The patients were followed through 1997.\u00a0The survival rates were determinated by Kaplan\u00adMeier method. For establishment of hazard ratios Cox analysis was used.\u00a0The five-year survival rates for [&hellip;]","og_url":"https:\/\/medrazgl.si\/prezivetje-bolnic-z-rakom-jajcnikov\/","og_site_name":"Dru\u0161tvo Medicinski razgledi","article_published_time":"2013-09-06T13:21:00+00:00","article_modified_time":"2013-09-10T06:49:35+00:00","author":"Urban Neudauer","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Urban Neudauer","Est. reading time":"1 minute"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/medrazgl.si\/prezivetje-bolnic-z-rakom-jajcnikov\/#article","isPartOf":{"@id":"https:\/\/medrazgl.si\/prezivetje-bolnic-z-rakom-jajcnikov\/"},"author":{"name":"Urban Neudauer","@id":"https:\/\/medrazgl.si\/#\/schema\/person\/39b1336c1302c42805280dd6a1e7069c"},"headline":"Survival of Patients with Ovarian Cancer","datePublished":"2013-09-06T13:21:00+00:00","dateModified":"2013-09-10T06:49:35+00:00","mainEntityOfPage":{"@id":"https:\/\/medrazgl.si\/prezivetje-bolnic-z-rakom-jajcnikov\/"},"wordCount":222,"commentCount":0,"articleSection":["4","Clinical research paper","Gynecology and Obstetrics","Oncology"],"inLanguage":"en-US","potentialAction":[{"@type":"CommentAction","name":"Comment","target":["https:\/\/medrazgl.si\/prezivetje-bolnic-z-rakom-jajcnikov\/#respond"]}]},{"@type":"WebPage","@id":"https:\/\/medrazgl.si\/prezivetje-bolnic-z-rakom-jajcnikov\/","url":"https:\/\/medrazgl.si\/prezivetje-bolnic-z-rakom-jajcnikov\/","name":"Survival of Patients with Ovarian Cancer - Dru\u0161tvo Medicinski razgledi","isPartOf":{"@id":"https:\/\/medrazgl.si\/#website"},"datePublished":"2013-09-06T13:21:00+00:00","dateModified":"2013-09-10T06:49:35+00:00","author":{"@id":"https:\/\/medrazgl.si\/#\/schema\/person\/39b1336c1302c42805280dd6a1e7069c"},"breadcrumb":{"@id":"https:\/\/medrazgl.si\/prezivetje-bolnic-z-rakom-jajcnikov\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/medrazgl.si\/prezivetje-bolnic-z-rakom-jajcnikov\/"]}]},{"@type":"BreadcrumbList","@id":"https:\/\/medrazgl.si\/prezivetje-bolnic-z-rakom-jajcnikov\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/medrazgl.si\/en\/"},{"@type":"ListItem","position":2,"name":"Survival of Patients with Ovarian Cancer"}]},{"@type":"WebSite","@id":"https:\/\/medrazgl.si\/#website","url":"https:\/\/medrazgl.si\/","name":"Dru\u0161tvo Medicinski razgledi","description":"Dru\u0161tvo Medicinski razgledi","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/medrazgl.si\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Person","@id":"https:\/\/medrazgl.si\/#\/schema\/person\/39b1336c1302c42805280dd6a1e7069c","name":"Urban Neudauer","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/secure.gravatar.com\/avatar\/9dcee367d5b99deae63e16a3c461f1a7dae2d29d171f2dbc5f3de73145bb4f36?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/9dcee367d5b99deae63e16a3c461f1a7dae2d29d171f2dbc5f3de73145bb4f36?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/9dcee367d5b99deae63e16a3c461f1a7dae2d29d171f2dbc5f3de73145bb4f36?s=96&d=mm&r=g","caption":"Urban Neudauer"},"url":"https:\/\/medrazgl.si\/en\/author\/urban-neudauer\/"}]}},"_links":{"self":[{"href":"https:\/\/medrazgl.si\/en\/wp-json\/wp\/v2\/posts\/3500","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/medrazgl.si\/en\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/medrazgl.si\/en\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/medrazgl.si\/en\/wp-json\/wp\/v2\/users\/17"}],"replies":[{"embeddable":true,"href":"https:\/\/medrazgl.si\/en\/wp-json\/wp\/v2\/comments?post=3500"}],"version-history":[{"count":0,"href":"https:\/\/medrazgl.si\/en\/wp-json\/wp\/v2\/posts\/3500\/revisions"}],"wp:attachment":[{"href":"https:\/\/medrazgl.si\/en\/wp-json\/wp\/v2\/media?parent=3500"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/medrazgl.si\/en\/wp-json\/wp\/v2\/categories?post=3500"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/medrazgl.si\/en\/wp-json\/wp\/v2\/tags?post=3500"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}